MX358316B - Uso de cáscaras de aguacate para obtener insaponificables de aguacate enriquecidos en hidrocarburos alifáticos saturados y en esteroles. - Google Patents

Uso de cáscaras de aguacate para obtener insaponificables de aguacate enriquecidos en hidrocarburos alifáticos saturados y en esteroles.

Info

Publication number
MX358316B
MX358316B MX2014008535A MX2014008535A MX358316B MX 358316 B MX358316 B MX 358316B MX 2014008535 A MX2014008535 A MX 2014008535A MX 2014008535 A MX2014008535 A MX 2014008535A MX 358316 B MX358316 B MX 358316B
Authority
MX
Mexico
Prior art keywords
avocado
sterols
aliphatic hydrocarbons
saturated aliphatic
material enriched
Prior art date
Application number
MX2014008535A
Other languages
English (en)
Other versions
MX2014008535A (es
Inventor
Philippe Msika
Jacques Legrand
Sébastien Garnier
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of MX2014008535A publication Critical patent/MX2014008535A/es
Publication of MX358316B publication Critical patent/MX358316B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/06Production of fats or fatty oils from raw materials by pressing
    • C11B1/08Production of fats or fatty oils from raw materials by pressing by hot pressing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/02Pretreatment
    • C11B1/04Pretreatment of vegetable raw material
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/06Production of fats or fatty oils from raw materials by pressing
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/10Production of fats or fatty oils from raw materials by extracting

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de cáscaras de aguacate con el fin de obtener un insaponificable de aguacate enriquecido en hidrocarburos alifáticos saturados y en esteroles, donde dichas cáscaras de aguacate representan del 5 al 50% en peso en relación con el peso total de la aguacate utilizada; la invención también hace referencia a un método para obtener un insaponificable de aguacate enriquecido en hidrocarburos alifáticos saturados y en esteroles de al menos cáscaras de aguacate, donde dichas cáscaras de aguacate representan del 5 al 50% en peso en relación con el peso total de la aguacate utilizada; la invención también hace referencia a un insaponificable de aguacate enriquecido en hidrocarburos alifáticos saturados y en esteroles, que se puede obtener mediante este método; por último, la invención hace referencia a un insaponificable de aguacate enriquecido en hidrocarburos alifáticos saturados y en esteroles para su uso como fármaco, ventajosamente en la prevención y/o el tratamiento de trastornos de los tejidos conjuntivos tales como artrosis, patologías articulares tales como reumatismo o enfermedades periodontales tales como gingivitis o periodontitis.
MX2014008535A 2012-01-13 2013-01-14 Uso de cáscaras de aguacate para obtener insaponificables de aguacate enriquecidos en hidrocarburos alifáticos saturados y en esteroles. MX358316B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1250367A FR2985665B1 (fr) 2012-01-13 2012-01-13 Utilisation de peau d'avocat pour obtenir un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques satures et en sterols
PCT/EP2013/050580 WO2013104793A1 (fr) 2012-01-13 2013-01-14 Utilisation de peau d'avocat pour obtenir un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques satures et en sterols

Publications (2)

Publication Number Publication Date
MX2014008535A MX2014008535A (es) 2014-08-21
MX358316B true MX358316B (es) 2018-08-14

Family

ID=38572710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008535A MX358316B (es) 2012-01-13 2013-01-14 Uso de cáscaras de aguacate para obtener insaponificables de aguacate enriquecidos en hidrocarburos alifáticos saturados y en esteroles.

Country Status (19)

Country Link
US (1) US9439938B2 (es)
EP (1) EP2802336B1 (es)
KR (1) KR102115042B1 (es)
CN (2) CN104168906B (es)
AR (1) AR089705A1 (es)
AU (1) AU2013208884B2 (es)
BR (1) BR112014017083B1 (es)
CA (1) CA2863494C (es)
CL (1) CL2014001833A1 (es)
ES (1) ES2864598T3 (es)
FR (1) FR2985665B1 (es)
IL (1) IL233586A0 (es)
MX (1) MX358316B (es)
PE (1) PE20142296A1 (es)
PL (1) PL2802336T3 (es)
RU (1) RU2632111C2 (es)
TW (1) TWI592163B (es)
WO (1) WO2013104793A1 (es)
ZA (1) ZA201405771B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6360118B2 (ja) * 2016-09-20 2018-07-18 本田技研工業株式会社 剥離装置及び剥離ステーション
FR3086508B1 (fr) * 2018-09-27 2021-10-08 Expanscience Lab Procede de preparation d'avocats deshydrates par sechage micro-ondes
CN113046170B (zh) * 2021-03-26 2022-03-11 大连奥川生物科技有限公司 富含呋喃类脂不皂化物的鳄梨油制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2041594A5 (es) * 1969-04-30 1971-01-29 Expanscience
FR2678632B1 (fr) * 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
EP1343860B1 (en) * 2000-12-21 2012-01-25 AarhusKarlshamn Denmark A/S A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter
US6994875B2 (en) * 2002-07-29 2006-02-07 Laboratoires Expanscience Process for obtaining a furan lipid-rich unsaponifiable material from avocado
FR2870742B1 (fr) * 2004-05-28 2008-03-14 Expanscience Laboratoires Sa Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
WO2010026595A2 (en) * 2008-09-08 2010-03-11 Polyol Biotech Ltd. Cosmetic compositions comprising polyhydroxyltate fatty alcohols and derivatives and uses thereof
FR2984748B1 (fr) * 2011-12-26 2017-02-10 Expanscience Lab Utilisation d'avocats mous entiers pour obtenir une huile d'avocat riche en insaponifiable

Also Published As

Publication number Publication date
CL2014001833A1 (es) 2014-10-03
AR089705A1 (es) 2014-09-10
WO2013104793A1 (fr) 2013-07-18
RU2632111C2 (ru) 2017-10-02
ZA201405771B (en) 2015-11-25
FR2985665B1 (fr) 2015-10-02
AU2013208884A1 (en) 2014-08-28
TW201332562A (zh) 2013-08-16
KR102115042B1 (ko) 2020-05-25
PE20142296A1 (es) 2015-01-23
CN110604760A (zh) 2019-12-24
TWI592163B (zh) 2017-07-21
AU2013208884B2 (en) 2017-06-01
CA2863494A1 (fr) 2013-07-18
US20150005273A1 (en) 2015-01-01
IL233586A0 (en) 2014-08-31
RU2014132231A (ru) 2016-03-10
BR112014017083A2 (pt) 2017-06-13
BR112014017083B1 (pt) 2021-02-09
EP2802336B1 (fr) 2021-03-03
PL2802336T3 (pl) 2021-08-30
CN104168906B (zh) 2019-10-15
KR20140114425A (ko) 2014-09-26
FR2985665A1 (fr) 2013-07-19
CA2863494C (fr) 2020-06-09
MX2014008535A (es) 2014-08-21
CN104168906A (zh) 2014-11-26
US9439938B2 (en) 2016-09-13
ES2864598T3 (es) 2021-10-14
EP2802336A1 (fr) 2014-11-19

Similar Documents

Publication Publication Date Title
PH12015500106B1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
MX351336B (es) Uso de aguacates blandos enteros para obtener un aceite de aguacate rico en masa no saponificable.
WO2013061161A3 (en) New combination therapies for treating neurological disorders
EA201590655A1 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
NZ716977A (en) Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of acute and sub-acute cough, urge to cough and chronic cough, in respiratory diseases
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
GB201318761D0 (en) Compounds for the treatment of neuropsychiatric disorders
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
EP3712264A8 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
MX346576B (es) Metodos y composiciones adecuados para promover piel sana.
MX2015006120A (es) Compuestos novedosos oralmente biodisponibles que modulan el control de la respiracion, y metodos de uso de los mismos.
MX2016009306A (es) Reequilibrado inmunologico epicutaneo.
MX2018006247A (es) Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
MX2015015036A (es) Metodos para mejorar los perfiles de lipidos utilizando atrasentan.
MX354598B (es) Uso de neuregulina para tratar lesion de nervio periferico.
MX2018005756A (es) Ubicacion como objetivo del receptor 2 de formilo-peptido/receptor de lipoxina a4 (fpr2/alx) para el tratamiento de enfermedades cardiacas.
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX365193B (es) Uso de semilla de palta para obtener aceite de palta enriquecido en alquil polioles y/o sus derivados acetilados.
MX358316B (es) Uso de cáscaras de aguacate para obtener insaponificables de aguacate enriquecidos en hidrocarburos alifáticos saturados y en esteroles.
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
AR092104A1 (es) LAQUINIMOD EN EL TRATAMIENTO DE LOS TRASTORNOS MEDIADOS POR EL ACIDO g-AMINOBUTIRICO (GABA)
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.

Legal Events

Date Code Title Description
FG Grant or registration